An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Canada

University of Calgary, Calgary, Alberta

Ottawa Hospital Research Institute, Ottawa, Ontario

CIUSSS du Saguenay-Lac-Saint-Jean, Saguenay